Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Products may not be licenced in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Qualitative assay intended for an in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation.
|Model Compatible With||Vanadis Core®|
|Product Brand Name||Vanadis Core®|